Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations

• Váldodahkkit: Carolina Moraes de Souza (Dahkki), Tayfun Tanir (Dahkki), Marvin Orellana (Dahkki), Aster Escalante (Dahkki), Michael Sandor Koeris (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2021-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Within this second piece of the two-part series of phage manufacturing considerations, we are examining the creation of a drug product from a drug substance in the form of formulation, through to fill-finish. Formulation of a drug product, in the case of bacteriophage products, is often considered o...